{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.3157.4020",
  "meta": {
    "versionId": "14",
    "lastUpdated": "2022-03-08T01:01:59.000-05:00",
    "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "extension": [ {
    "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
    "valueDate": "2022-03-08"
  } ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4020",
  "identifier": [ {
    "system": "urn:ietf:rfc:3986",
    "value": "urn:oid:2.16.840.1.113883.3.3157.4020"
  } ],
  "version": "20200821",
  "name": "Fibrinolytic Therapy",
  "title": "Fibrinolytic Therapy",
  "status": "active",
  "date": "2022-03-08T01:02:00-05:00",
  "publisher": "Yale",
  "expansion": {
    "identifier": "urn:uuid:93f1c45a-37d5-41cc-b30c-5bf05bb6eb2b",
    "timestamp": "2023-08-21T11:22:38-04:00",
    "total": 22,
    "offset": 0,
    "parameter": [ {
      "name": "count",
      "valueInteger": 1000
    }, {
      "name": "offset",
      "valueInteger": 0
    } ],
    "contains": [ {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "08072023",
      "code": "1804799",
      "display": "alteplase 100 MG Injection"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "08072023",
      "code": "1804804",
      "display": "alteplase 50 MG Injection"
    }, {
      "system": "http://loinc.org",
      "version": "2.74",
      "code": "21464-3",
      "display": "Plasminogen activator urokinase type [Presence] in Tissue"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "08072023",
      "code": "313212",
      "display": "tenecteplase 50 MG Injection"
    }, {
      "system": "http://loinc.org",
      "version": "2.74",
      "code": "43636-0",
      "display": "Plasminogen activator tissue type [Presence] in Platelet poor plasma by Chromogenic method"
    }, {
      "system": "http://loinc.org",
      "version": "2.74",
      "code": "5971-7",
      "display": "Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay"
    }, {
      "system": "http://loinc.org",
      "version": "2.74",
      "code": "5972-5",
      "display": "Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay --20 minutes post venistasis"
    }, {
      "system": "http://loinc.org",
      "version": "2.74",
      "code": "5973-3",
      "display": "Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay --10 minutes post venistasis"
    }, {
      "system": "http://loinc.org",
      "version": "2.74",
      "code": "5981-6",
      "display": "Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay"
    }, {
      "system": "http://loinc.org",
      "version": "2.74",
      "code": "5982-4",
      "display": "Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay --20 minutes post venistasis"
    }, {
      "system": "http://loinc.org",
      "version": "2.74",
      "code": "5983-2",
      "display": "Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay --10 minutes post venistasis"
    }, {
      "system": "http://loinc.org",
      "version": "2.74",
      "code": "5986-5",
      "display": "Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method"
    }, {
      "system": "http://loinc.org",
      "version": "2.74",
      "code": "5987-3",
      "display": "Plasminogen activator tissue type [Mass/volume] in Platelet poor plasma by Chromogenic method"
    }, {
      "system": "http://loinc.org",
      "version": "2.74",
      "code": "5988-1",
      "display": "Plasminogen activator tissue type [Mass/volume] in Platelet poor plasma by Chromogenic method --10 minutes post venistasis"
    }, {
      "system": "http://loinc.org",
      "version": "2.74",
      "code": "5989-9",
      "display": "Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method --10 minutes post venistasis"
    }, {
      "system": "http://loinc.org",
      "version": "2.74",
      "code": "5990-7",
      "display": "Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method --20 minutes post venistasis"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "08072023",
      "code": "763138",
      "display": "reteplase 10 UNT Injection"
    }, {
      "system": "http://loinc.org",
      "version": "2.74",
      "code": "88659-8",
      "display": "Timing of thrombolytic administration in relation to cardiac arrest"
    }, {
      "system": "http://loinc.org",
      "version": "2.74",
      "code": "LP16885-3",
      "display": "Plasminogen activator tissue type Ag"
    }, {
      "system": "http://loinc.org",
      "version": "2.74",
      "code": "LP16889-5",
      "display": "Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex"
    }, {
      "system": "http://loinc.org",
      "version": "2.74",
      "code": "LP16891-1",
      "display": "Plasminogen activator tissue type"
    }, {
      "system": "http://loinc.org",
      "version": "2.74",
      "code": "LP265990-4",
      "display": "Timing of thrombolytic administration in relation to cardiac arrest"
    } ]
  }
}